Biomedical impact of splicing mutations revealed through exome sequencing

Area of Science:

• Molecular Biology
• Genetics
• Genomics

Background:

• Splicing is crucial for eukaryotic gene expression, removing introns and joining exons.
• Alternative splicing (AS) significantly increases proteome diversity by creating multiple mRNA isoforms from a single gene.
• Disruptions in splicing, including AS, are linked to diseases such as myotonic dystrophy and cystic fibrosis, and are implicated in cancer.

Purpose of the Study:

• To review the disease relevance of aberrant splicing.
• To describe a novel approach for identifying rare mutations affecting splicing regulation by starting from disease phenotype.
• To highlight the potential of exome sequencing in uncovering splicing mutations in inherited diseases.

Main Methods:

• Exome sequencing to identify sequence variations associated with disease states.
• Molecular and bioinformatic analyses to detect rare mutations impacting splicing regulation.
• Focusing on disease phenotype to guide the discovery of novel splicing mutations.

Main Results:

• Exome sequencing is a reliable method for finding disease-associated sequence variations.
• Current exome sequencing studies have primarily focused on coding region variants, neglecting splicing mutations.
• Splicing mutations likely contribute more frequently to inherited diseases than currently recognized.

Conclusions:

• Aberrant splicing plays a significant role in human diseases.
• Investigating splicing mutations through exome sequencing offers a promising avenue for understanding rare genetic disorders.
• This approach has the potential to reveal the substantial impact of splicing mutations in human pathology.